Is Weight Loss–Induced Muscle Mass Loss Clinically Relevant?
This Viewpoint explores the effects of weight loss achieved through GLP-1–based antiobesity medications on weight regain, fat-free mass, and skeletal muscle mass in people with obesity.
Gespeichert in:
Veröffentlicht in: | JAMA : the journal of the American Medical Association 2024-07, Vol.332 (1), p.9 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | This Viewpoint explores the effects of weight loss achieved through GLP-1–based antiobesity medications on weight regain, fat-free mass, and skeletal muscle mass in people with obesity. |
---|---|
ISSN: | 0098-7484 1538-3598 1538-3598 |
DOI: | 10.1001/jama.2024.6586 |